UPDATE : Friday, June 14, 2019
FDA approves 1st treatment for liver cancer in decade
The U.S. Food and Drug Administration Thursday expanded the approved use of...
by Constance Williams  |  2017-04-28 11:25
Boryung’s 1Q sales hit ₩99.8 billion
Boryung Pharmaceuticals보령제약 recorded sales of 99.8 billion won ($88.3 milli...
by Lee Hye-seon  |  2017-04-27 14:59
How Daewoong released Korea’s 1st generic drug in US?
All eyes of Korean drugmakers are on Daewoong Pharmaceutical, as it has ach...
by Lee Hye-seon  |  2017-04-27 13:28
Expectations rise about new bio drug going global
AFSTYLA, a hemophilia therapy developed by SK Chemicals SK케미칼이 jointly with...
by Lee Hye-seon  |  2017-04-26 18:06
Customized subfertility therapy to debut in Korea
REKOVELLE (compound: follitropin delta), the personalized subfertility trea...
by Lee Hye-seon  |  2017-04-26 16:22
FDA warns 14 firms against selling false cancer-curing products
The U.S. Food and Drug Administration (FDA) posted warning letters on Tuesd...
by Constance Williams  |  2017-04-26 10:49
Samsung Bioepis wins first FDA approval for biosimilar drug
The U.S. Food and Drug Administration Friday approved Samsung Bioepis’ rheu...
by Marian Chu  |  2017-04-24 18:18
Pharmacists oppose introduction of corporate-style drugstores
Koreans work hard. They are second-hardest working people among OECD nation...
by Constance Williams  |  2017-04-21 16:51
Baxter allegedly forces workers to quit under disguise of advice
Baxter Korea, the Korean offshoot of the U.S.-based pharmaceutical company,...
by Marian Chu  |  2017-04-20 16:17
Daewoong launches first generic antibiotic in US
Daewoong Pharmaceutical대웅제약 has launched its generic antibiotic “Meropenem”...
by Constance Williams  |  2017-04-19 18:03
State auditors ‘fail to confirm Hanmi’s cover-up of clinical results’
The government’s top administrative watchdog has found Hanmi Pharmaceutical...
by Marian Chu  |  2017-04-18 15:23
FDA stuns Eli-Lilly, Incyte by rejecting rheumatoid arthritis drug
Eli Lilly and Co. and Incyte Corp. said Friday that the U.S. Food and Drug ...
by Constance Williams  |  2017-04-17 17:17
Cancer patients protest against Novartis Korea
Novartis Korea’s targeted anticancer treatment, Gleevec, is in danger of lo...
by Marian Chu  |  2017-04-17 15:04
Korean firms stage ‘let’s-save-our drug’ drive
The “let’s-save-our drug” campaign -- initiated by the domestic medicine di...
by Lee Hye-seon  |  2017-04-14 15:30
Hanmi preempts global incontinence drug market
Hanmi Pharma한미약품(CEOs Woo Jong-soo우종수 and Kwon Se-chang권세창) has grabbed ano...
by Lee Hye-seon  |  2017-04-12 18:37
FDA approves first drug for tardive dyskinesia
The U.S. Food and Drug Administration (FDA) said Tuesday it approved Ingrez...
by Constance Williams  |  2017-04-12 16:11
KPAC 2017 focuses on ‘open innovation’ by pharma industry
Korean and foreign pharmaceutical companies got together at the Korea Pharm...
by Marian Chu  |  2017-04-11 18:52
FDA rejects Merck’s bid to expand Januvia label
Merck & Co. said the U.S. FDA had rejected its additional non-disclosure ag...
by Constance Williams  |  2017-04-11 11:39
Hanmi makes public 23 new drug pipelines on its website
Hanmi Pharm한미약품 (CEO Kwon Se-Chang권세창 and Woo Jong-soo우종수), announced 23 ne...
by Marian Chu  |  2017-04-10 18:04
K-Pharma Academy promotes Korean-Latin American ties
The Korea Health Industry Development Institute (KHIDI) completed its annua...
by Constance Williams  |  2017-04-10 15:40
Back to Top